Trial Outcomes & Findings for Resident Supervision Index: Assessing Feasibility and Validity (NCT NCT00680368)
NCT ID: NCT00680368
Last Updated: 2015-04-28
Results Overview
Describes agreement between physician resident and attending physician assessment of total resident supervision time for a given patient and patient care clinical encounter.
COMPLETED
97 participants
24-hours
2015-04-28
Participant Flow
Participant milestones
| Measure |
Group 1
The study began with 112 responders: 75 physician residents and 37 attending physicians. Only 60 of the 75 residents had been supervised by one of the 37 participating attending physicians. Thus, 15 residents were dropped from study. Both resident and their attending physician were surveyed to report total supervision time for each of 148 clinical encounters with 143 patients. There were more clinical encounters than patients because some patients had more than one encounter. There were more physician residents than attending physicians because attending physicians may have supervised more than one resident. There were more clinical encounters than residents because a resident may be involved in more than one clinical encounter with a patient.
|
|---|---|
|
Overall Study
STARTED
|
112
|
|
Overall Study
COMPLETED
|
97
|
|
Overall Study
NOT COMPLETED
|
15
|
Reasons for withdrawal
| Measure |
Group 1
The study began with 112 responders: 75 physician residents and 37 attending physicians. Only 60 of the 75 residents had been supervised by one of the 37 participating attending physicians. Thus, 15 residents were dropped from study. Both resident and their attending physician were surveyed to report total supervision time for each of 148 clinical encounters with 143 patients. There were more clinical encounters than patients because some patients had more than one encounter. There were more physician residents than attending physicians because attending physicians may have supervised more than one resident. There were more clinical encounters than residents because a resident may be involved in more than one clinical encounter with a patient.
|
|---|---|
|
Overall Study
not supervised, not eligible
|
15
|
Baseline Characteristics
Resident Supervision Index: Assessing Feasibility and Validity
Baseline characteristics by cohort
| Measure |
Physician Residents and Attending Physicians
n=112 Participants
includes physician residents and attending physicians who were asked to sit through a face to face interview with a research assistant following a clinical encounter with a patient
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
112 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
40 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
72 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 24-hoursDescribes agreement between physician resident and attending physician assessment of total resident supervision time for a given patient and patient care clinical encounter.
Outcome measures
| Measure |
Physician Residents and Attending Physicians
n=97 Participants
Sample included 112, including 60 physician residents and 37 attending physicians
|
|---|---|
|
Intraclass Correlation Coefficient Between Physician Resident and Attending Physician.
|
.69 Intraclass Correlation Coefficient
Interval 0.57 to 0.78
|
SECONDARY outcome
Timeframe: 24 hoursAssesses the test-retest reliability of repeated responses for resident physicians only to report the total time spent during resident supervision.
Outcome measures
| Measure |
Physician Residents and Attending Physicians
n=60 Participants
Sample included 112, including 60 physician residents and 37 attending physicians
|
|---|---|
|
Intraclass Correlation Coefficient Assessing Test-retest Reliability for Resident Physicians
|
.93 Intraclass Correlation Coefficient
Interval 0.91 to 0.95
|
SECONDARY outcome
Timeframe: 24 hoursAssesses the test-retest reliability among repeated responses to surveys administered to attending physicians only.
Outcome measures
| Measure |
Physician Residents and Attending Physicians
n=37 Participants
Sample included 112, including 60 physician residents and 37 attending physicians
|
|---|---|
|
Intraclass Correlation Coefficient for Test-retest Reliability for Attending Physicians
|
.88 Intraclass Correlation Coefficient
Interval 0.82 to 0.91
|
Adverse Events
Group 1
Serious adverse events
| Measure |
Group 1
n=75 participants at risk
Sample included 75 resident physicians. No adverse events noted.
|
|---|---|
|
General disorders
quality of care
|
0.00%
0/75 • Collected during the 3-months when subjects were interviewed only.
|
|
Psychiatric disorders
Mental breakdown
|
0.00%
0/75 • Collected during the 3-months when subjects were interviewed only.
|
Other adverse events
| Measure |
Group 1
n=75 participants at risk
Sample included 75 resident physicians. No adverse events noted.
|
|---|---|
|
General disorders
dissatisfaction with education experience
|
0.00%
0/75 • Collected during the 3-months when subjects were interviewed only.
|
|
Eye disorders
Eye strain
|
0.00%
0/75 • Collected during the 3-months when subjects were interviewed only.
|
Additional Information
T. Michael Kashner, PhD, PI
Loma Linda VA Healthcare System
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place